| Hospital Cuts Hit Health-Care Workers With one hospital closing and others slashing budgets, the city's healthcare-job marketplace could get crowded in the coming days, and some employees fear they could be facing a long spell without work. online.wsj.com |
Amazon and American Oriental Bioengineering: How to Benefit From Inefficient Share Prices Jason Tillberg submits:Valuation of shares of stock by both the public and institutions are dreadfully inefficient. This of course creates great opportunities, but also creates potential short term misfortune as share prices go to further extremes of what you may have already considered either expensive or inexpensive.Take for example Amazon, (AMZN) who first saw its shares trading on the stock exchange with its IPO (Initial Public Offering) in May of 1997. Complete Story » seekingalpha.com |
Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling Kaushik Paul submits:On July 15, 2010, the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee is expected to review the marketing application of VIVUS Inc. (VVUS)’s Qnexa (formerly known as VI-0521), designed for the treatment of obesity.The Endocrinologic and Metabolic Drugs Advisory Committee is a panel of experts that reviews and evaluates data regarding the safety and effectiveness of marketed and investigational human drugs for use in the treatment of hormonal and metabolic disorders. The committee also provides the FDA with scientific and medical guidance to facilitate the marketing approval decisions of the drugs under review.Complete Story » seekingalpha.com |
New Data Supports Valdoxan - Video New Data Supports Valdoxan’s® Unique Clinical Signature feedproxy.google.com |
Sanofi Lines Up Genzyme Financing French drug maker Sanofi is lining up more financing as it contemplates raising its $18.5 billion bid for U.S. biotech Genzyme. online.wsj.com |